Vandetanib
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 941 publications
Tyrosine Kinase Inhibitor Therapy in Metastatic Medullary Thyroid Carcinoma: Real-World Data from Turkish Oncology Group.
Journal: Journal of clinical medicine
Published: March 01, 2026
Metastatic Medullary Thyroid Carcinoma Without Identifiable Primary Tumor Within the Thyroid Gland, Presenting with Initial Lymph Node Metastasis Followed by Distant Peritoneal Metastasis: A Case Report of a Rare Phenomenon.
Journal: Journal of clinical medicine
Published: February 19, 2026
Can We Develop Glioma Subtype-Specific Precision Medicines? An Integrative Machine Learning Pipeline for Biomarker Discovery and Drug Repurposing for Glioblastoma and Low-Grade Glioma.
Journal: Omics : a journal of integrative biology
Published: December 30, 2025
Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies.
Journal: Biomedicines
Published: November 21, 2025
Selpercatinib plus cemiplimab in RET positive medullary thyroid cancer patient with skin cancers.
Journal: Tumori
Published: November 10, 2025
Targeting VEGFR2 inhibition within a spatially-confined conduit promotes nerve self-resolution and alleviates mechanical allodynia.
Journal: Bioactive materials
Published: October 19, 2025
Medicinal chemistry perspective on quinazoline derivatives: Sustainable synthetic routes, anticancer evaluation, and SAR analysis.
Journal: European journal of medicinal chemistry
Published: October 12, 2025
Vascular endothelial cells and angiogenesis.
Journal: Pharmacological research
Published: October 04, 2025
Cardiovascular toxicities of major oral targeted therapies used in solid tumor
Journal: Bulletin du cancer
Published: September 30, 2025
Cutaneous Coccidioidomycosis Mimicking Rosacea in Immunosuppressed Patient, Arizona, USA, 2024.
Journal: Emerging infectious diseases
Published: September 29, 2025
Medullary Thyroid Carcinoma That Progressed From Low- to High-Grade During Treatment: A Case Report.
Medullary Thyroid Carcinoma That Progressed From Low- to High-Grade During Treatment: A Case Report.
Journal: Pathology international
Published: September 17, 2025
Real-world external control arm for the single-arm LIBRETTO-001 trial of selpercatinib in RET-mutation-positive medullary thyroid cancer: RECALIB-RET.
Journal: ESMO open
Published: September 16, 2025
Last Updated: 04/28/2026